Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cobra gains on first trading day

Contract manufacturer Cobra Bio-Manufacturing (LSE:CBF) gained 2.5p to 102.5p

Read the full 93 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE